How changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.
Michael Dohmann, Georgetown University Law Center, Class of 2019
Advertisement
Articles by Michael Dohmann, Georgetown University Law Center, Class of 2019
Advertisement
Latest Updated Articles
Regulatory Deharmonization: How Brexit May Effect the Medical Products Industry, Public HealthPublished: June 28th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
Low-Dose Aspirin Linked to Lower Cardiovascular Risk in Type 2 Diabetes
4
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
5
